PGI2 as a regulator of CD4+ subset differentiation and function

Prostaglandins and Other Lipid Mediators

Volumn 96, Issue 1-4, 2011, Pages 21-26

  Boswell, Madison G ^a   Zhou, Weisong ^a   Newcomb, Dawn C ^a   Peebles Jr , R Stokes ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cell.; Interferon ; PGI2; T cell

Indexed keywords

CICAPROST; GAMMA INTERFERON; ILOPROST; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROSTACYCLIN; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; DRUG DERIVATIVE; PROSTAGLANDIN DERIVATIVE; VASODILATOR AGENT;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MEMBRANE DEPOLARIZATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; EPOPROSTENOL; HUMANS; ILOPROST; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PROSTAGLANDINS, SYNTHETIC; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TH2 CELLS; VASODILATOR AGENTS;

EID: 81155133766     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.08.003     Document Type: Review

References (32)

1. S. Moncada, R. Gryglewski, S. Bunting, and J.R. Vane An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
2. N. Whittaker, S. Bunting, and J. Salmon The chemical structure of prostaglandin X (prostacyclin) Prostaglandins 12 1976 915 928
3. R.J. Helliwell, L.F. Adams, and M.D. Mitchell Prostaglandin synthases: recent developments and a novel hypothesis Prostaglandins Leukot Essent Fatty Acids 70 2004 101 113 (Pubitemid 38141900)
4. E.M. Smyth, and G.A. Fitzgerald Human prostacyclin receptor Vitam Horm 65 2002 149 165 (Pubitemid 135763174)
5. J. Szczeklik, A. Szczeklik, and R. Nizankowski Prostacyclin for pulmonary hypertension Lancet 2 1980 1076 (Pubitemid 11225358)
6. D.M. Aronoff, C.M. Peres, and C.H. Serezani Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities J Immunol 178 2007 1628 1634 (Pubitemid 46154634)
7. W. Zhou, K. Hashimoto, and K. Goleniewska Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells J Immunol 178 2007 702 710 (Pubitemid 46095142)
8. W. Zhou, T.S. Blackwell, and K. Goleniewska Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells J Leukoc Biol 81 2007 809 817 (Pubitemid 46393559)
9. I.Y. Lee, E.M. Ko, S.H. Kim, D.I. Jeoung, and J. Choe Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center J Immunol 175 2005 1658 1664 (Pubitemid 41023069)
10. D. Gatto, and R. Brink The germinal center reaction J Allergy Clin Immunol 126 2010 898 907
11. A.K. Abbas The control of T cell activation vs. tolerance Autoimmun Rev 2 2003 115 118 (Pubitemid 37443847)
12. D. Amsen, C.G. Spilianakis, and R.A. Flavell How are T(H)1 and T(H)2 effector cells made? Curr Opin Immunol 21 2009 153 160
13. X.P. Yang, K. Ghoreschi, and S.M. Steward-Tharp Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 Nat Immunol 12 2011 247 254
14. N. Manel, D. Unutmaz, and D.R. Littman The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 9 2008 641 649 (Pubitemid 351714729)
15. D.C. Newcomb, M.G. Boswell, and W. Zhou Human Th17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production J Allergy Clin Immunol 127 2011 1006 1013
16. A. Jager, and V.K. Kuchroo Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation Scand J Immunol 72 2010 173 184
17. S. Nakajima, T. Honda, and D. Sakata Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity J Immunol 184 2010 5595 5603
18. C.H. Kuo, Y.C. Ko, and S.N. Yang Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation J Mol Med 89 2011 29 41
19. K. Hashimoto, B.S. Graham, and M.W. Geraci Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness J Virol 78 2004 10303 10309 (Pubitemid 39258355)
20. B.S. Graham, T.R. Johnson, and R.S. Peebles Immune-mediated disease pathogenesis in respiratory syncytial virus infection Immunopharmacology 48 2000 237 247
21. Y. Takahashi, S. Tokuoka, and T. Masuda Augmentation of allergic inflammation in prostanoid IP receptor deficient mice Br J Pharmacol 137 2002 315 322
22. K. Nagao, H. Tanaka, M. Komai, T. Masuda, S. Narumiya, and H. Nagai Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice Am J Respir Cell Mol Biol 2003
23. Z. Jaffar, K.S. Wan, and K. Roberts A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen J Immunol 169 2002 5997 6004 (Pubitemid 35291707)
24. Z. Jaffar, M.E. Ferrini, M.C. Buford, G.A. Fitzgerald, and K. Roberts Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma J Immunol 179 2007 6193 6203
25. M. Idzko, H. Hammad, and M. van Nimwegen Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function J Clin Invest 117 2007 464 472 (Pubitemid 46203975)
26. M.A. Carey, D.R. Germolec, and J.A. Bradbury Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice Am J Respir Crit Care Med 167 2003 1509 1515 (Pubitemid 37363360)
27. R.S. Peebles Jr. , K. Hashimoto, and J.D. Morrow Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice Am J Respir Crit Care Med 165 2002 1154 1160 (Pubitemid 34415827)
28. L.E. Harrington, R.D. Hatton, and P.R. Mangan Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132 (Pubitemid 41541790)
29. D.C. Newcomb, W. Zhou, and M.L. Moore A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production J Immunol 182 2009 5317 5321
30. H. Li, J.A. Bradbury, and R.T. Dackor Cyclooxygenase-2 (COX-2) regulates Th17 cell differentiation during allergic lung inflammation Am J Respir Crit Care Med 2011
31. Y. Iwakura, and H. Ishigame The IL-23/IL-17 axis in inflammation J Clin Invest 116 2006 1218 1222
32. Zhou W, Huckabee MM, Dowell DR, et al. Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalitis. PLoS One, personal communication.